Omega-3 fatty acids for intermittent claudication. [PDF]
Mohammady M +4 more
europepmc +1 more source
Pharmacologic Profile of A<sub>2A</sub> Adenosine Receptors: Identifying Patients with Intermittent Claudication and Associated Myocardial Ischemia. [PDF]
Deharo P +11 more
europepmc +1 more source
Sex differences in outcomes of exercise therapy for patients with intermittent claudication: A scoping review. [PDF]
Weaver ML +7 more
europepmc +1 more source
Extracorporeal shock wave therapy for peripheral arterial disease-related intermittent claudication: a systematic review and meta-analysis. [PDF]
Tang P +8 more
europepmc +1 more source
Propionyl-L-carnitine for intermittent claudication. [PDF]
Kamoen V +5 more
europepmc +1 more source
Market competition influences practice patterns in management of patients with intermittent claudication in the vascular quality initiative. [PDF]
Weaver ML +8 more
europepmc +1 more source
Improvement of Gait Biomechanics after Endovascular Therapy for Patients with Intermittent Claudication Associated with Aortoiliac Occlusive Disease. [PDF]
Ogasawara N +9 more
europepmc +1 more source
Derivation and validation of a non-invasive optoacoustic imaging biomarker for detection of patients with intermittent claudication. [PDF]
Caranovic M +19 more
europepmc +1 more source
A guideline-based preference elicitation tool to enhance shared decision-making in supervised exercise therapy for patients with intermittent claudication: a process evaluation. [PDF]
Marcellis LHM +5 more
europepmc +1 more source

